General Information of the Compound
| Compound ID |
CP0377295
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(R)-5-((E)-3-Hydroxy-4-phenyl-but-1-enyl)-1-[4-(1H-tetrazol-5-ylsulfanyl)-butyl]-pyrrolidin-2-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C19H25N5O2S
|
||||||||||||||||||
| Molecular Weight |
387.509
|
||||||||||||||||||
| Canonical SMILES |
OC(Cc1ccccc1)\C=C\[C@H]1CCC(=O)N1CCCCSc1nnn[nH]1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C19H25N5O2S/c25-17(14-15-6-2-1-3-7-15)10-8-16-9-11-18(26)24(16)12-4-5-13-27-19-20-22-23-21-19/h1-3,6-8,10,16-17,25H,4-5,9,11-14H2,(H,20,21,22,23)/b10-8+/t16-,17?/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
CSYHDBJGSZIDDS-FNPGKKEOSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02279, Prostacyclin receptor
Protein ID: PT01054, Prostaglandin D2 receptor
Protein ID: PT01205, Prostaglandin E2 receptor EP1 subtype
Protein ID: PT00948, Prostaglandin E2 receptor EP2 subtype
Protein ID: PT01367, Prostaglandin E2 receptor EP3 subtype
Protein ID: PT01534, Prostaglandin E2 receptor EP4 subtype
Protein ID: PT01823, Prostaglandin F2-alpha receptor
Protein ID: PT01819, Thromboxane A2 receptor